| |
| |
|
| Insider
Information: |
Ehrlich Christopher B |
| Relationship: |
Director |
| City: |
Franklin |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
516,275 |
|
|
Indirect Shares
|
2,152,555 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$4,424,061 |
|
|
| Total
Shares |
2,668,830 |
|
|
| Total
Value |
$4,424,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomimetic Therapeutics, Inc. |
BMTI |
Director |
2013-03-01 |
0 |
2013-03-01 |
0 |
Premium* |
|
|
Anesiva Inc |
ANSVQ |
10% Owner |
2006-02-28 |
2,237 |
2006-02-28 |
21,869 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director, 10% Owner |
2009-01-30 |
0 |
2011-09-21 |
1,983,884 |
Premium* |
|
|
Effector Therapeutics Ord Shs |
EFTR |
Director |
2022-10-04 |
35,213 |
2022-10-04 |
143,202 |
Premium* |
|
|
Phoenix Biotech Acquisition Corp. |
PBAX |
Director |
2024-02-14 |
478,825 |
2024-02-14 |
3,600 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
27 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
27 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
